American Society for Clinical Pathology - ASC/SIL Ratio for Cytotechnologists: A Surrogate Marker of Screening Sensitivity

ASC/SIL Ratio for Cytotechnologists: A Surrogate Marker of Screening Sensitivity

Andrew A. Renshaw, MD
Department of Pathology, Baptist Hospital of Miami, Miami, FL

Majorie Deschênes, MD
Department of Pathology, Centre Hospitalier Affilié Universitaire de Québec, Quebec City, Canada

Manon Auger, MD
Department of Pathology, McGill University Health Center and McGill University, Montreal, Canada

Keywords: ASC/SIL ratio; Gynecologic cytology; Quality control; Diagnostic accuracy

Upon completion of this activity, you will be able to:

describe the differences between routine (full) review of negative gynecologic cytology cases and rapid prescreening.
discuss the utility of the atypical squamous cell/squamous intraepithelial lesion (ASC/SIL) ratio for cytotechnologists.

The ASCP designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation n the activities.

This activity meets MOC Part II Lifelong Learning requirements. A self-assessment option is available for pathologists attending this program to earn SAM credits for Maintenance of Certification, Part II Self-Assessment Modules (MOC-SAM) for part of the course. For MOC brochure, click here.

List Price

$20.00

Member Price

$15.00

From:
Email:
To:
Email:
Subject:
Message: